We may earn commissions if you use the recommended services on this site.  

Marinus Pharmaceuticals Launches Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV

Latest Business News

Marinus Pharmaceuticals Launches Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV

Marinus Pharmaceuticals, a pharmaceutical company focused on treating seizure disorders, has initiated the Marinus Access Program for ZTALMY® (ganaxolone) oral suspension CV. This global managed access program enables physicians to request ZTALMY for eligible patients with seizures associated with CDKL5 deficiency disorder (CDD) in regions where the product is not commercially available, subject to local regulatory requirements. The program will be managed by Durbin, a leader in specialized pharmaceutical distribution.

Expanding Patient Access

The Marinus Access Program aims to provide broader access to ZTALMY for patients with critical unmet medical needs. By collaborating with commercial partners in Europe, China, and the MENA region, Marinus Pharmaceuticals is advancing its global access strategy and offering pathways for appropriate CDD patients in regions where approved treatment options are lacking.

Clinical Trial Results

The U.S. Food and Drug Administration and European Commission approvals of ZTALMY in CDD are supported by data from the Phase 3 Marigold trial. Patients treated with ZTALMY showed a significant reduction in major motor seizure frequency compared to the placebo group. The clinical development program demonstrated the efficacy, safety, and tolerability of ZTALMY. In conclusion, the Marinus Access Program provides an opportunity for eligible patients with CDD to access ZTALMY in regions where commercial availability is limited. This initiative aligns with Marinus Pharmaceuticals' commitment to addressing unmet medical needs and expanding global patient access to innovative therapeutics.

Marinus Pharmaceuticals' Global Access Program: Implications for New Businesses

Marinus Pharmaceuticals' launch of the Marinus Access Program for ZTALMY® (ganaxolone) oral suspension CV is a game changer, especially for new businesses in the pharmaceutical industry. The program, which allows physicians to request ZTALMY for eligible patients with seizures associated with CDKL5 deficiency disorder (CDD) in regions where the product isn't commercially available, is a bold step towards addressing unmet medical needs.

Global Access Strategy

The Marinus Access Program is a blueprint for how new businesses can collaborate with commercial partners across different regions to expand access to their products. This strategy is particularly beneficial in regions where approved treatment options are lacking, creating opportunities for new businesses to fill these gaps.

Significance of Clinical Trial Results

The FDA and European Commission approvals of ZTALMY, supported by data from the Phase 3 Marigold trial, underscore the importance of robust clinical trials in gaining regulatory approvals. New businesses can learn from Marinus Pharmaceuticals' approach to clinical development, which demonstrated the efficacy, safety, and tolerability of ZTALMY. In conclusion, Marinus Pharmaceuticals' Global Access Program provides valuable lessons for new businesses on how to address unmet medical needs and expand global patient access to innovative therapeutics.
Story First Published at: https://financialpost.com/pmn/business-wire-news-releases-pmn/marinus-pharmaceuticals-initiates-global-access-program-for-ztalmy-ganaxolone-oral-suspension-cv
Brought to you by BusinessFormation.io
Know Your State's Registered Agent Requirements: What is a Registered Agent
Learn How To Create An LLC: What Is An LLC and How To Start an LLC Online
Business Formation Services: View Top 3 Online LLC Filing Companies

LLC Filing & Registered Agent Services

Compare Online LLC Filing Services Today

We work with the market leaders in business formation and registered agent services.

Getting started is simple and inexpensive. Form your business today & secure your brand name before someone beats you to it! Click below to view the Top 3 Best LLC and registered agent service providers.
View Top 3 Providers Now
x

Filing An LLC Can Be Complicated

Streamline Your LLC Filing Online for $39

Northwest Registered Agent is the best-rated service for first time filers.

Get professional LLC formation & registered agent services for only $39 + state filing fee. This offers includes your full LLC setup, plus a private business address, lifetime support, and more.

Trusted by Millions. Save 82% Today.